{
    "nct_id": "NCT04807894",
    "official_title": "Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo",
    "inclusion_criteria": "* 60-90 yo Female\n* Postmenopausal\n* Recurrent UTIs (three or more culture confirmed symptomatic episodes of UTI or two or more in the past 6 months).\n* English Proficiency\n* Unable or unwilling to use topical estrogen.\n* Patients with history of or current endometrial or breast cancer and current aromatase inhibitor therapy may also be included in study.\n* Patient on oral estrogen therapy may be included.\n* Patient with slings, prior vaginal surgery or pessary may be included.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 60 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Current UTI/ Dipstick and culture positive (> trace leukocytes or nitrites)\n* Antibiotic (vaginal or oral) use in the last 4 weeks\n* Current sexually transmitted infection\n* Chronic Foley catheter use or chronic ureteral stent placement.\n* Vaginal probiotic use in the last 4 weeks\n* Patient currently using vaginal estrogen.\n* Post-void Residual Volume >150 mL or current diagnosis of urinary retention\n* Non-evaluated hematuria (> trace on dipstick, microscopic, gross)\n* Unable to complete study tasks or comply with follow up.",
    "miscellaneous_criteria": ""
}